ENTITY
Seagen

Seagen (SGEN US)

40
Analysis
Health CareUnited States
Seagen Inc. operates as a biotechnology company. The Company discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases, as well as offers antibody-drug conjugate technology designed to deliver cell-killing agents directly to tumor cells. Seagen serves customers worldwide.
more
Company Event01 Nov 2023 20:00 • Upcoming
Add To Calendar
Company Event02 Aug 2023 19:00 • Upcoming
Add To Calendar
Company Event28 Apr 2023 04:00 • Upcoming
Add To Calendar
Company Event16 Feb 2023 05:30 • Latest
Company Event28 Oct 2022 04:30
x